These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 34785889)

  • 61. Development of stable tocopherol succinate-loaded ethosomes to enhance transdermal permeation: In vitro and in vivo characterizations.
    Akhtar N; Akhtar N
    J Cosmet Dermatol; 2022 Oct; 21(10):4942-4955. PubMed ID: 35274433
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Novel iontophoretic drug delivery of estradiol with alendronate for osteoporosis treatment.
    Li S; Chang J
    Pak J Pharm Sci; 2023 Mar; 36(2):541-546. PubMed ID: 37530163
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Influence of electronic and formulation variables on transdermal iontophoresis of tacrine hydrochloride.
    Patel N; Jain S; Madan P; Lin S
    Pharm Dev Technol; 2015 Jun; 20(4):442-57. PubMed ID: 24467234
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Transdermal iontophoretic delivery of a liquid lipophilic drug by complexation with an anionic cyclodextrin.
    Juluri A; Narasimha Murthy S
    J Control Release; 2014 Sep; 189():11-8. PubMed ID: 24950431
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Transdermal lipid vesicular delivery of iloperidone: Formulation, in vitro and in vivo evaluation.
    Londhe VY; Bhasin B
    Colloids Surf B Biointerfaces; 2019 Nov; 183():110409. PubMed ID: 31386933
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Penetration enhancer-containing spanlastics (PECSs) for transdermal delivery of haloperidol: in vitro characterization, ex vivo permeation and in vivo biodistribution studies.
    Fahmy AM; El-Setouhy DA; Ibrahim AB; Habib BA; Tayel SA; Bayoumi NA
    Drug Deliv; 2018 Nov; 25(1):12-22. PubMed ID: 29219628
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Evaluation of acyclovir cream and gel formulations for transdermal iontophoretic delivery.
    Siddoju S; Sachdeva V; Friden PM; Banga AK
    Ther Deliv; 2012 Mar; 3(3):327-38. PubMed ID: 22833993
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Design, formulation and optimization of valsartan transdermal gel containing iso-eucalyptol as novel permeation enhancer: preclinical assessment of pharmacokinetics in Wistar albino rats.
    Ahad A; Aqil M; Kohli K; Sultana Y; Mujeeb M
    Expert Opin Drug Deliv; 2014 Aug; 11(8):1149-62. PubMed ID: 24830648
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Design and Characterization of Atenolol Transdermal Therapeutic Systems: Enhancement of Permeability via Iontophoresis.
    Keerthi H; Panakanti PK; Yamsani MR
    PDA J Pharm Sci Technol; 2012; 66(4):318-32. PubMed ID: 22767881
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Enhanced Permeation of Methotrexate via Loading into Ultra-permeable Niosomal Vesicles: Fabrication, Statistical Optimization, Ex Vivo Studies, and In Vivo Skin Deposition and Tolerability.
    Al-Mahallawi AM; Fares AR; Abd-Elsalam WH
    AAPS PharmSciTech; 2019 Apr; 20(5):171. PubMed ID: 31004239
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Transdermal delivery of insulin from poloxamer gel: ex vivo and in vivo skin permeation studies in rat using iontophoresis and chemical enhancers.
    Pillai O; Panchagnula R
    J Control Release; 2003 Apr; 89(1):127-40. PubMed ID: 12695068
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Formulation of niosomal gel for enhanced transdermal lopinavir delivery and its comparative evaluation with ethosomal gel.
    Patel KK; Kumar P; Thakkar HP
    AAPS PharmSciTech; 2012 Dec; 13(4):1502-10. PubMed ID: 23104306
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Anti-inflammatory ethosomal nanoformulation in combination with iontophoresis in chronic wound healing: An ex vivo study.
    Mombeiny R; Tavakol S; Kazemi M; Mehdizadeh M; Hasanzadeh A; Karimi Babaahmadi M; Abedi A; Keyhanvar P
    IET Nanobiotechnol; 2021 Dec; 15(9):710-718. PubMed ID: 34694760
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Comparison of liposomal drug formulations for transdermal iontophoretic drug delivery.
    Malinovskaja-Gomez K; Espuelas S; Garrido MJ; Hirvonen J; Laaksonen T
    Eur J Pharm Sci; 2017 Aug; 106():294-301. PubMed ID: 28625748
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Development of ibuprofen nanoliposome for transdermal delivery: Physical characterization, in vitro/in vivo studies, and anti-inflammatory activity.
    Gaur PK; Bajpai M; Mishra S; Verma A
    Artif Cells Nanomed Biotechnol; 2016; 44(1):370-5. PubMed ID: 25211229
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Controlled Iontophoretic Delivery
    Singhal M; Merino V; Rosini M; Cavalli A; Kalia YN
    Mol Pharm; 2019 Aug; 16(8):3460-3468. PubMed ID: 31241959
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Enhanced Both in vitro and in vivo Kinetics by SLNs Induced Transdermal System of Furosemide: A Novel Approach.
    Mannam R; Yallamalli IM
    Recent Pat Drug Deliv Formul; 2017; 11(3):187-197. PubMed ID: 29189185
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A novel method to enhance the efficiency of drug transdermal iontophoresis delivery by using complexes of drug and ion-exchange fibers.
    Xin C; Li-hong W; Yue Y; Ya-nan G; Qi-fang W; Yang Y; San-ming L
    Int J Pharm; 2012 May; 428(1-2):68-75. PubMed ID: 22405965
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Ultrasound-assisted transdermal delivery of alendronate for the treatment of osteoporosis.
    Li B; Huang G; Ma Z; Qin S
    Acta Biochim Pol; 2020 Jun; 67(2):173-179. PubMed ID: 32558528
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Enhancement of bioavailability through transdermal drug delivery of paliperidone palmitate-loaded nanostructured lipid carriers.
    Raval S; Jani P; Patil P; Thakkar P; Sawant K
    Ther Deliv; 2021 Aug; 12(8):583-596. PubMed ID: 34286598
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.